Table II.
Relative expression of CK19 and vimentin in ADSCs following adipose ECM induction, as determined by immunofluorescence staining.
| Control
|
ECM
|
|||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 1 day | 3 days | 5 days | 7 days | 9 days | 1 day | 3 days | 5 days | 7 days | 9 days | |
| CK19 | 3.32±0.32 | 4.32±0.43b | 5.43±0.35b | 7.32±0.54b | 5.43±0.68b | 3.33±0.31 | 8.43±0.73a,b | 12.32±0.11a,b | 16.43±1.23a,b | 12.84±1.22a,b |
| Vimentin | 2.43±0.22 | 3.55±0.39b | 4.64±0.34b | 6.11±0.54b | 4.32±0.52b | 2.74±0.24 | 5.64±0.49a,b | 8.73±0.84a,b | 10.83±0.88a,b | 8.12±0.83a,b |
a
P<0.05 vs. the control group;
b
P<0.05 vs. the previous time point; CK19, cytokeratin 19; ADSCs, adipose-derived stem cells; ECM, extracellular matrix.